Finasteride Sexual Dysfunction Side Effects Poorly Reported

General Discussion Media & Awareness
#1

Medical Daily headline:

“Finasteride’s Sexual Dysfunction Side Effects Poorly Reported In Male Baldness Studies”

The story begins:

“Out of 34 clinical trials reviewed on the popular hair loss drug finasteride, zero were found to properly relay safety information on the drug’s controversial side effect of sexual dysfunction. Researchers from Northwestern University’s Feinberg School of Medicine report on the findings in a new meta-analysis published in JAMA Dermatology.”

Full story here:

medicaldaily.com/finasteride … ies-327754

And full research here:

archderm.jamanetwork.com/article … id=2212246

And JAMA podcast here:

archderm.jamanetwork.com/multime … Interviews

And Thomas Moore editorial here:

archderm.jamanetwork.com/article … id=2212243

#2

Can someone please post this research on Reddit? r/tressless

#3

Guys, please retweet/favorite the tweets on this topic from @MRKMalfeasance. Please also follow that account, as well as the @RecallPropecia and @PFSFoundation accounts.

#4

And look what we have here: Agence France Presse (AFP) headline:

“Questions Persist about Sexual Effects of Baldness Drug”

AFP, in case you’re not familiar, is a major European newswire service – global, in fact.

My favorite line is this:

“Merck did not immediately respond to an AFP request for comment.”

(Wassup, Kenneth C. Frazier? Why you stickin’ yo head in the sand with all them slugs and worms?)

The full story here:

straitstimes.com/news/world/ … g-20150401

#5

Yahoo picking up the story now, too:

news.yahoo.com/questions-persist … 01862.html

#6

Yippee-ki-yay, motherfucker.

The truth shall set you (Kenneth C. Frazier) free.

Go tell it on the mountain!

#7

Note this quote from the companion JAMA podcast:

"We know now, more than 20 years after [finasteride] was first approved, that it is unequivocally true that the drug impairs male sexual function. And we can see this in all our standard references: the package insert, the major textbooks. So the facts are clear. The question is, Why didn’t they show up more clearly in the clinical trials? And the short answer is that clinical trials are really carefully designed to measure benefits, and really deserve to be called the gold standard. It turns out that [clinical trials] are much weaker when it comes to ascertain the adverse effects.”

—Thomas J. Moore, Senior Scientist, Drug Safety and Policy, Institute for Safe Medication Practices

Has anyone seen Kenneth C. Frazier? Oh—there he go, hidin’ under Bill Cosby’s sofa.

#8

Good to see that the PFS Foundation is already picking up the Belknap study on its homepage:

pfsfoundation.org/

#9

Add The Daily Mail to the mix, the world’s largest online newspaper.

The Mail is running the Agence France Presse story, headlined “Questions Persist about Sexual Effects of Baldness Drug.”

dailymail.co.uk/wires/afp/ar … -drug.html

This time, however, Merck released a statement to AFP, which is (and I quote):

Merck “conducted well-designed clinical trials and stands behind the results, which were reported to the FDA and regulatory agencies around the world.”

Wow, what high-priced team of flacks and attorneys crafted that?

Moreover, is EVERY Merck employee a psychopath? How long will they keep this charade up?

Meanwhile, the truth shall set you free. Maybe SOME day, Mr. Kenneth C. Frazier, you’ll learn to tell it. It’s really not that hard. All you gotta do it look into your heart and ask your late parents, “Mom, dad, what would YOU do in my situation?”

And they would no doubt respond, “Do the right thing, son. Tell the truth. Pull that poison off the market because it’s devastating the lives of countless men around the globe, to say nothing of their loved ones. We didn’t raise you, son, to devastate lives. So make us proud, and – for once in your career – put patients over profits. Now do us proud, son.”

#10

Now add Le Presse, a Canadian national newspaper, to the mix:

lapresse.ca/vivre/sante/2015 … lvitie.php

Poor Mr. Frazier, it seems the world is closing in on you.

#11

And the hits just keep on coming.

Now they’re talking about the Northwestern study in Brazil:

em.com.br/app/noticia/intern … ecas.shtml

Anyone want to bet how long before the Japanese pick up the story? I’d say by tomorrow morning.

And the Japanese do NOT take kindly to being poisoned by American pharmaceutical companies. Remember Pearl Harbor?

#12

Add Malay Mail to the mix:

themalaymailonline.com/featu … erformance

The headline there is: “Study Finds Hair Loss Drug Impedes Sexual Performance”

And Malay Mail is based, of course, in Malaysia – which is not Japan. But still, we’re getting close.

#13

Also add Business Standard, which headlines its story (actually by the Asian newswire service ANI), “Sexual Dysfunction Side Effects Poorly Reported in Hair Loss Drug Trials”

That report here:

business-standard.com/articl … 556_1.html

And Business Standard is, in case you’re not aware, based in India.

It does seem the world is closing in on you, Mr. Frazier. You ain’t makin’ many new friends here. So you might want to change yo ways.

Meanwhile, stay tuned for more coverage.

And more, and more and more.

#14

Getting closer (to Japan, that is). The Central News Agency in Beijing, China, just picked up the story, headlined “Side Effects of Baldness Drug on Sexual Function Should Not Be Overlooked.”

The report here:

discovery.163.com/15/0402/18/AM7 … 125LI.html

Seems like most of the world knows that finateride can be very dangerous.

But how come Merck doesn’t know? Didn’t they develop the drug? Isn’t their motto “Be well”?

Hmmmmm.

#15

Well considering China has 1.3 billion people and Japan may have what? 100 million if that? I think its a lot more important that its being covered in China, especially concerning their government’s firewall on information.

#16

Agreed, BP7667.

Am just trying to (shhhh) give the flacks and attorneys at Merck who monitor these pages a little something to think about – which I HOPE is this:

Y’all know you’re guilty. Y’all know that finasteride harms a certain subset of its users. So if y’all have any humanity at all, y’all will pull YOUR COMPANY’S product off the market. And for those of y’all who don’t have the power to do that, at least take your boss(es) aside and let them know you’re not happy about working for a company whose product(s) are doing irreparable harm – both physical and psychological – to thousands of men around the globe.

Think about it: If y’all were were working for 7-11 and ya’ll learned that y’all’s microwave burritos were poisoning ya’ll’s customers, what would y’all do?

That’s right, y’all would say something – if that were only to warn customers NOT to buy those dangerous burritos.

That’s ALL we’re talking about here, y’all.

Just trying our best to “do no harm.”

And this is America, so feel free to blow that whistle loud and clear.

Y’all won’t be punished. Y’all will be praised by the general public as heroes.

#17

And the hits just keep on… well, y’all know.

This time, it’s America’s very own Milwaukee Journal-Sentinel, whose story is headlined:

“What They Don’t Talk about When They Talk about an Anti-baldness Drug”

The full report – by Pulitzer Prize-winning journalist Mark Johnson – here:

jsonline.com/blogs/news/298472581.html

Feel free to thank Mr. Johnson at this email address: markjohnson@journalsentinel.com

#18

And while we’re at it, how about another Brazilian newspaper, Estado de Minas?

EM’s report here:

sites.uai.com.br/app/noticia/sau … sexu.shtml

Poor Mista Fraza. Can no longer hide the truth. And this media storm is just the tip of the iceberg.

But don’t fret, you can always hang with… Bill Cosby.

#19

Seems the Mexicans, too, have an interest in informing their citizens that finasteride might not be as safe as Kenneth C. Frazier insists it is.

Here we have the Puebla-based newspaper Periodico Digital:

periodicodigital.mx/2015/04/ … os-calvos/

#20

Just for fun, let’s add Columbia (as in Bogota) to the mix with this lead paragraph from El Nuevo Siglo:

“Ninguno de los 34 experimentos clínicos con finasterida, un fármaco muy popular para combatir la calvicie, provee datos suficientes sobre los posibles efectos secundarios en la sexualidad de sus consumidores, según un estudio publicado el miércoles.”

Which translates as:

“None of the 34 clinical trials for finasteride, a popular drug to fight baldness, provides sufficient information about possible side effects on the sexuality of their consumers, according to a study released Wednesday.”

The story here:

elnuevosiglo.com.co/articulo … alvos.html

Remember: Kenneth C. Frazier is shaping up to be the Bill Cosby of the pharmaceutical world.